See all treatments in the PatientsLikeMe system shared by patients just like you.
Brand Names:
Rebif
See also:
Interferon beta 1a
What is Interferon beta-1a SubQ injection?
Interferon beta-1a is an immunomodulator used to prevent episodes of symptoms and slow the development of disability in patients with relapsing-remitting multiple sclerosis. It comes as a solution to inject subcutaneously (under the skin) three times a week, ideally the same 3 days each week.
Read more...
1126 patients in the community are taking or have taken Interferon beta-1a SubQ injection.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Slow my MS progress | 966 | 85% |
| Other | 40 | 3% |
| Stiffness/spasticity | 14 | 1% |
| Fatigue | 13 | 1% |
| disease-related symptoms | 10 | <1% |
| General health | 8 | <1% |
| Don't know | 5 | <1% |
| Slow my Devic's progress | 2 | <1% |
| Pain | 2 | <1% |
| Anxiety | 1 | <1% |
| Balance Problems | 1 | <1% |
| Excessive daytime sleepiness (somnolence) | 1 | <1% |
| Emotional lability | 1 | <1% |
| MS | 1 | <1% |
| Depression | 1 | <1% |
| Treat my MSA | 1 | <1% |
| Sensation | 1 | <1% |
| Mobility | 1 | <1% |
| Treat Parkinson's | 1 | <1% |
| Brain fog | 1 | <1% |
Based on the patients currently taking Interferon beta-1a SubQ injection.
Top 10 (Show all)
All (Show Top 10)
| 0 - day | 0 mcg day | 0 mg day | 0 day | 0 - none | 0 mcg none | 0 mg none | 0 mL none | 0 mcg week | 0 mg week | 0 week | 0.14 mcg week | 0.44 mg week | 0.5 mcg week | 0.5 mg week | 0.5 mL week | 0.22 mg day | 0.25 mcg day | 0.25 mg day | 1 g week | 1 mcg week | 1 week | 0.3 mcg day | 0.3 mg day | 1.1 week | 0.44 mcg week | 0.5 mcg week | 0.44 mcg day | 0.44 mg day | 0.44 day | 0.5 mcg day | 0.5 mg day | 0.3 mcg day | 0.3 mg day | 0.8 mcg week | 0.75 mg day | 1 mcg week | 3 mcg week | 3 mg week | 3 week | 1 mcg day | 1 mg day | 1 day | 4.4 mcg week | 2.2 mcg week | 8.8 mcg week | 3 mcg week | 3 mcg day | 3 mg day | 4.4 mcg week | 15 mcg week | 20 mg week | 3 mg day | 22 mcg week | 22 mg week | 24 mcg week | 10 mcg week | 30 mcg week | 30 mg week | 8.8 mg day | 33 mg week | 10 day | 12 mcg week | 40 mcg week | 40.5 mcg week | 44 mcg week | 44 mg week | 44 week | 60 mg week | 0 mcg none | 9.42854 mcg day | 22 mcg week | 66 mcg week | 66 mg week | 10 mg day | 20 mcg day | 20 mg day | 22 mcg day | 22 mg day | 22 day | 25 mg day | 88 mcg week | 30 mcg week | 33 mcg week | 30 mcg day | 112 mcg week | 40 mcg week | 120 mg week | 126 mcg week | 18.85708 mcg day | 44 mcg week | 131.996920061599 mcg week | 18.85752 mcg day | 132 mcg week | 132 mg week | 132 week | 134 mcg week | 40 mcg day | 40 day | 41 mcg day | 43 mg day | 152 mg week | 22 mcg day | 44 g day | 44 mcg day | 44 mg day | 44 day | 153.996920061599 mcg week | 176 mcg week | 100 mcg week | 300 week | 0 mcg none | 0 mg none | 44 mcg day | 44 other day | 307.993840123198 mcg week | 132 mcg week | 395.990760184796 mcg week | 138 mcg week | 144 mcg week | 125 day | 132 mcg day | 461.990760184796 mcg week | 144 mg day | 200 mcg week | 100 mcg day | 200 mcg day | 200 mg day | 923.981520369593 mcg week | 923.981520369593 mg week | 321 mcg week | 300 mg day | 200 g day | 250 mcg day | 500 mcg day | 300 other day | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1
|
16
|
3
|
21
|
2
|
9
|
1
|
1
|
33
|
5
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
2
|
2
|
9
|
1
|
3
|
3
|
1
|
3
|
3
|
1
|
2
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
2
|
3
|
2
|
3
|
1
|
1
|
2
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
7
|
4
|
2
|
1
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
44
|
18
|
2
|
1
|
1
|
1
|
11
|
8
|
2
|
1
|
1
|
1
|
5
|
5
|
2
|
1
|
2
|
1
|
2
|
2
|
1
|
2
|
1
|
1
|
3
|
113
|
1
|
1
|
65
|
16
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
11
|
2
|
51
|
87
|
22
|
1
|
1
|
1
|
1
|
2
|
1
|
32
|
1
|
2
|
1
|
7
|
1
|
1
|
1
|
1
|
4
|
1
|
1
|
1
|
3
|
2
|
3
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
||
How long current patients have been taking Interferon beta-1a SubQ injection or how long patients were taking Interferon beta-1a SubQ injection before stopping.
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Side effects too severe | 169 | 54% | |
| Did not seem to work | 91 | 29% | |
| Doctor's advice | 66 | 21% | |
| Other | 49 | 16% | |
| Personal research | 14 | 5% | |
| Expense | 12 | 4% | |
| Not indicated | 10 | 3% | |
| Course of treatment ended | 6 | 2% |
Results from 68 patient evaluations. See the overall results and all individual evaluations.
| Major | 18% | 11 |
|---|---|---|
| Moderate | 13% | 8 |
| Slight | 11% | 7 |
| None | 11% | 7 |
| Can't tell | 46% | 28 |
Slow my MS progress
| Severe | 10% | 7 |
|---|---|---|
| Moderate | 38% | 26 |
| Mild | 41% | 28 |
| None | 10% | 7 |
Top reported side-effects include: Muscle ache, whole body, injection site redness, Headaches
Summary results are based on 68 individual responses. For more information, see overall results for Adherence, Burden and Cost.
See all evaluation results for Interferon beta-1a SubQ injection